Cover Image

Radiosynthesis and Preclinical Evaluation of Bispecific PSMA/FAP Heterodimers for Tumor Imaging

Due to tumor heterogeneity and complex tumor-stromal interactions in multicellular systems, the efficiency of monospecific tracers for tumor diagnosis and therapy is currently limited. In light of the evidence of prostate-specific membrane antigen (PSMA) overexpression in tumor cells and fibroblast...

Full description

Saved in:

Bibliographic Details
Main Authors:	Kongzhen Hu (Author), Li Li (Author), Yong Huang (Author), Shimin Ye (Author), Jiawei Zhong (Author), Qingsong Yan (Author), Yuhua Zhong (Author), Lilan Fu (Author), Pengju Feng (Author), Hongsheng Li (Author)
Format:	Book
Published:	MDPI AG, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis and Preclinical Evaluation of Radio-Iodinated GRPR/PSMA Bispecific Heterodimers for the Theranostics Application in Prostate Cancer
by: Ayman Abouzayed, et al.
Published: (2019)

Automated Radiosynthesis, Preliminary In Vitro/In Vivo Characterization of OncoFAP-Based Radiopharmaceuticals for Cancer Imaging and Therapy
by: Francesco Bartoli, et al.
Published: (2022)

Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method
by: Marco Nicola Iannone, et al.
Published: (2024)

Targeted Endoradiotherapy with Lu<sub>2</sub>O<sub>3</sub>-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image
by: Myrna Luna-Gutiérrez, et al.
Published: (2022)

Preclinical evaluation and pilot clinical study of [18F]AlF-labeled FAPI-tracer for PET imaging of cancer associated fibroblasts
by: Kongzhen Hu, et al.
Published: (2022)

The Future of PSMA-Targeted Radionuclide Therapy: An Overview of Recent Preclinical Research
by: Eline A.M. Ruigrok, et al.
Published: (2019)

Optimization and scale up of production of the PSMA imaging agent [18F]AlF-P16-093 on a custom automated radiosynthesis platform
by: David Alexoff, et al.
Published: (2024)

Expression of FAP in Oral Leukoplakia and Oral Squamous Cell Carcinoma
by: Ran Li, et al.
Published: (2024)

Combining mathematical modeling, in vitro data and clinical target expression to support bispecific antibody binding affinity selection: a case example with FAP-4-1BBL
by: Javier Sanchez, et al.
Published: (2024)

Radiosynthesis and Preclinical Evaluation of [<sup>99m</sup>Tc]Tc-Tigecycline Radiopharmaceutical to Diagnose Bacterial Infections
by: Syeda Marab Saleem, et al.
Published: (2024)

In vitro and in vivo analyses of eFAP: a novel FAP-targeting small molecule for radionuclide theranostics and other oncological interventions
by: Circe D. van der Heide, et al.
Published: (2024)

Convergent Synthesis of Two Fluorescent Ebselen-Coumarin Heterodimers
by: Jim Küppers, et al.
Published: (2016)

Retinoid X receptor heterodimers in hepatic function: structural insights and therapeutic potential
by: Renjie Xu, et al.
Published: (2024)

Fibroblast activation protein (FAP) as a novel metabolic target
by: Miguel Angel Sánchez-Garrido, et al.
Published: (2016)

Optimization of Automated Radiosynthesis of Gallium-68-Labeled PSMA11 with Two [<sup>68</sup>Ge]Ge/[<sup>68</sup>Ga]Ga Generators: Fractional Elution or Prepurification?
by: Flore Durieux, et al.
Published: (2023)

The FAPα-activated prodrug Z-GP-DAVLBH inhibits the growth and pulmonary metastasis of osteosarcoma cells by suppressing the AXL pathway
by: Geni Ye, et al.
Published: (2022)

Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studies
by: Alexander Wurzer, et al.
Published: (2024)

A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture
by: Xiaohui Luan, et al.
Published: (2022)

Mu Opioid Receptor Heterodimers Emerge as Novel Therapeutic Targets: Recent Progress and Future Perspective
by: Li Zhang, et al.
Published: (2020)

Sublingual Atropine Administration as a Tool to Decrease Salivary Glands' PSMA-Ligand Uptake: A Preclinical Proof of Concept Study Using [<sup>68</sup>Ga]Ga-PSMA-11
by: Vincent Nail, et al.
Published: (2022)

Investigation of the enantioselectivity of acetylcholinesterase and butyrylcholinesterase upon inhibition by tacrine-iminosugar heterodimers
by: I. Caroline Vaaland, et al.
Published: (2023)

In vitro investigating of anticancer activity of new 7-MEOTA-tacrine heterodimers
by: Jana Janockova, et al.
Published: (2019)

Heterodimer Binding Scaffolds Recognition via the Analysis of Kinetically Hot Residues
by: Ognjen Perišić
Published: (2018)

Surgical treatment of familial adenomatous polyposis (FAP) of the colon on children.
by: M.U. Ismayilov, et al.
Published: (2024)

From the Gut to the Liver: Another Organ to Watch in FAP Patients
by: Spencer Paulson, et al.
Published: (2016)

Automation of the Radiosynthesis of Six Different 18F-labeled radiotracers on the AllinOne
by: Shihong Li, et al.
Published: (2016)

Radiosynthesis and Preclinical Evaluation of an <sup>18</sup>F-Labeled Triazolopyridopyrazine-Based Inhibitor for Neuroimaging of the Phosphodiesterase 2A (PDE2A)
by: Barbara Wenzel, et al.
Published: (2022)

Radiosynthesis and preclinical evaluation of [11C]SNX-ab as an Hsp90α,β isoform-selective PET probe for in vivo brain and tumour imaging
by: Romy Cools, et al.
Published: (2023)

FAP-α is an effective tool to evaluate stroma invasion of lung adenocarcinoma
by: Siping Xiong, et al.
Published: (2024)

Targeting FAPα-positive lymph node metastatic tumor cells suppresses colorectal cancer metastasis
by: Shuran Fan, et al.
Published: (2024)

Novel <it>APC </it>mutations in Czech and Slovak FAP families: clinical and genetic aspects
by: Vesela Kamila, et al.
Published: (2007)

Novel Preclinical and Radiopharmaceutical Aspects of [68Ga]Ga-PSMA-HBED-CC: A New PET Tracer for Imaging of Prostate Cancer
by: Matthias Eder, et al.
Published: (2014)

Pitfalls and solutions of the fully-automated radiosynthesis of [11C]metoclopramide
by: Verena Pichler, et al.
Published: (2019)

Rifampicin does not significantly affect the expression of Small heterodimer partner (SHP) in primary human hepatocytes
by: Petr ePavek, et al.
Published: (2012)

Keap1-Nrf2 Heterodimer: A Therapeutic Target to Ameliorate Sickle Cell Disease
by: Waseem Chauhan, et al.
Published: (2023)

Enrichment strategy and initial characterization of heterodimers enriched from a co-formulated cocktail of therapeutic antibodies against SARS-COV-2
by: Sophia Liu, et al.
Published: (2024)

Different PSMA Radiopharmaceuticals: A Comparative Study of [<sup>18</sup>F]F-PSMA-1007, [<sup>18</sup>F]F-JK-PSMA-7, and [<sup>99m</sup>Tc]Tc-PSMA-I&S in the Skeletal System
by: Zsófia Sára Mikó, et al.
Published: (2024)

Preclinical development of a bispecific HIV x CD3 DART molecule that redirects T cells to kill HIV envelope (env)-expressing cells
by: J.L. Nordstrom, et al.
Published: (2017)

Radiosynthesis and preclinical evaluation of a 68Ga-labeled tetrahydroisoquinoline-based ligand for PET imaging of C-X-C chemokine receptor type 4 in an animal model of glioblastoma
by: Piyapan Suwattananuruk, et al.
Published: (2024)

Design of PSMA ligands with modifications at the inhibitor part: an approach to reduce the salivary gland uptake of radiolabeled PSMA inhibitors?
by: Veronika Barbara Felber, et al.
Published: (2021)